Search
for
Sort by
Research 961–990 of 1000+
- Phytochemicals and novel delivery systems in alopecia management: An integrative review
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia
- Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis
- Lasers in the management of alopecia: a review of established therapies and advances in treatment
- Exploring the Gut Microbiome and Metabolome in Individuals with Alopecia Areata Disease
- The role of laser and energy-assisted drug delivery in the treatment of alopecia
- Treatments for alopecia areata: a network meta-analysis
- Inverse correlation between vitamin D and CRP levels in alopecia areata: A pilot study
- An Updated in the Management of Alopecia Areata
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Diphenylcyclopropenone and platelet‐rich plasma in the management of severe or recalcitrant alopecia areata
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Efficacy and Safety of Platelet-Rich Plasma Therapy in Alopecia Areata Patients: A Systematic Review
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Efficacy of Acupuncture and Moxibustion in Alopecia: A Narrative Review
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Drug Armamentarium for alopecia areata
- Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A systematic review
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata